Sperm bank market to hit $6.9 billion by 2033

Persistence Market Research says the global sperm bank market will grow from $5.3 billion in 2026 to $6.9 billion by 2033 as fertility preservation, assisted reproductive technologies and donor demand expand. North America leads the market, while rising infertility, delayed parenthood and better cryopreservation technology support growth worldwide.

Why it matters: - Fertility preservation and assisted reproduction are expanding access to family-planning options for people facing infertility, delayed parenthood or medical treatments. - Market growth signals rising demand for donor sperm services, storage and genetic screening across fertility clinics and reproductive healthcare providers. - The report projects a larger commercial market for a category tied to long-term reproductive planning and treatment access.

What happened: - Persistence Market Research valued the global sperm bank market at $5.3 billion in 2026. - The market is projected to reach $6.9 billion by 2033. - The forecast implies a 3.8% compound annual growth rate from 2026 to 2033. - North America leads the market. - The report cites advanced healthcare infrastructure, higher awareness, supportive regulations and broad adoption of assisted reproductive technologies as drivers in North America. - A sample report is available More information.

The details: - Donor sperm services hold the leading segment because of demand from infertility treatments and single-parent and LGBTQ+ family planning. - Fertility clinics are the dominant end-user segment because of higher patient volumes and broader reproductive healthcare services. - Hospitals, specialty reproductive centers and research institutions also contribute to demand. - Storage and preservation services are gaining traction as more people seek fertility preservation before medical treatment or delayed family planning. - Cryogenic storage technologies help maintain long-term specimen viability. - Digital donor databases and streamlined screening procedures improve service efficiency and customer experience. - A customization option is available Customize this report.

Between the lines: - The report points to a broader shift in reproductive healthcare toward earlier planning, wider donor acceptance and more technology-enabled matching and storage. - The strongest demand appears to come from clinical use cases rather than consumer awareness alone. - Regulatory differences, donor-anonymity rules, high treatment costs and uneven reimbursement still constrain growth in some markets. - Europe is an important secondary market, while Asia Pacific is emerging on the back of better infrastructure, higher incomes, medical tourism and growing awareness among younger adults.

What's next: - More investment in fertility clinics and reproductive healthcare infrastructure is likely to support continued market expansion. - Advances in cryopreservation, genetic screening, AI-assisted donor matching and automated lab systems may improve treatment outcomes and operational efficiency. - Greater awareness campaigns around fertility preservation, including before chemotherapy, could expand demand further. - Strategic partnerships among fertility clinics, research groups and reproductive healthcare providers may accelerate adoption.

The bottom line: - Sperm banking is moving from a niche service to a broader reproductive healthcare category, with demand anchored by infertility treatment, fertility preservation and changing family-planning patterns.